Application of angiotensin-converting enzyme inhibitors / angiotensin receptor blockers in STEMI patients in the north of Liaoning Province from 2013 to 2015

Abstract

Objective To understand the application of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers(ACEI/ARB)in patients with ST-segment elevation acute myocardial infarction(STEMI)from 2013 to 2015 and to investigate the relevant affecting inhibiting factors. Methods The clinical information of 242 STEMI patients from 7 hospitals in the north of Liaoning province from January 1st 2013 to December 31st 2015, including the baseline characteristics, medical history, cardiovascular risk factors, clinical characteristics on admission and during hospitalization, ACEI/ARB usage and the like. Results Patients with ACEI/ARB(107 cases)and those who did not take ACEI/ARB(135 cases)had statistically significant difference in the recent smoking history(less than 1 year)and the history of combined hypertension(P 0.05). In 3 years, ACEI has been used more than ARB. Conclusion There were obvious insufficient applications of ACEI/ARB in STEMI patients in the north of Liaoning province, the utilization rate has not been significantly improved during the past 3 years, the health department at all levels should propose solutions as soon as possible to improve the poor area of northern Liaoning STEMI patients with ACEI/ARB utilization, and give patients a more scientific and standard treatment. Key words: The north of Liaoning province; ST-segment elevation acute myocardial infarction; Angiotensin-converting enzyme inhibitors; AngiotensinⅡreceptor blocker